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“All life is an experiment. The more experiments 
you make the better “  
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ABSTRACT 
Reproduction of a mammalian organism involves inherited genetic programming and 
environmental factors that collectively shape organ development and function in the new 
offspring. One such factor are the indigenous microbiota and their interactions with the host. 
In mammals, the placenta ensures the supply of nutrition and oxygen to the fetus in utero. 
Microbes are thought to contribute to establishment of barrier functions, activation of the 
immune system and supply of nutrients to the host. The objectives of my thesis were to assess 
whether microbes can modulate barrier functions connected to the placenta, brain, and testis, 
as well as influence the physiological functions of these organs. All three have distinctive tissue 
barriers that control the passage of molecules between the blood and tissue in order to optimize 
function. 
Paper I – Maternal microbes influence placental development and reduce maternal 
metabolic stress during pregnancy. Germ-free (GF) pregnant mice exhibited elevated 
glucocorticoids levels and increased gluconeogenesis and ketone body production. As a result, 
these dams showed marked impairment of placental development and establishment of the 
blood-placental barrier (BPB), with impaired capillary microstructure and reduced expression 
of tight junction proteins (TJPs). Metabolically, GF dams showed altered lipid and 
carbohydrate metabolism and drastically reduced hepatic levels of glycogen, as well as elevated 
levels of angiopoietin-4 (ANGPTL4), which is known to inhibit lipoprotein lipase and thus 
lipogenesis.  
 
Paper II – Maternal microbes contribute to the establishment and integrity of the blood-
brain barrier (BBB). During intra-uterine life, the BBB in GF mice was more permeable than 
that of specific-pathogen-free (SPF) animals, a difference that persisted into adulthood and was 
associated with reduced expression of TJPs.  Exposure of adult GF mice to the gut microbiota 
of SPF animals reduced this permeability and up-regulated the expression of some TJPs.  
Furthermore, perfusion with Evans blue revealed that monocolonization of the intestine of adult 
GF mice with either Clostridium tyrobutyricum, a bacterial strain that produces butyrate, or 
Bacteroides thetaiotaomicron, which produces mainly acetate and propionate, was sufficient 
to reduce BBB permeability. Moreover, oral administration of the bacterial metabolite butyrate 
mimicked this effect.  This effect of gut microbiota and butyrate may be mediated by an 
epigenetic mechanism, since administration of butyrate or monocolonization with Clostridium 
tyrobutyricum elevated levels of histone acetylation in brain lysates. 
 
 Paper III – Gut microbes modulate the permeability of the blood-testis barrier (BTB) and 
regulate endocrine functions of the testis. Establishment of the BTB, which normally occurs  
16 days postpartum, was delayed in GF mice.  Perfusion with Evans blue demonstrated 
increased BTB permeability associated with reduced expression of TJPs in these same mice 
during adulthood.  The testis- pituitary axis was also affected by the lack of gut microbiota, 
since GF mice exhibited lower serum levels of gonadotropins (LH and FSH) and lower 
intratesticular levels of testosterone than the SPF animals. Interestingly, exposure of GF mice 
to Clostridium tyrobutyricum restored the integrity of the BTB and normalized testosterone 
levels.  
 
In conclusion, the present work documents the influence of indigenous microbiota on the 
functions of the murine BPP, BBB and BTB, as well as their ability to support the mother 
during pregnancy. These findings suggest that microbes contribute to programming during 
critical windows of development. 
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1 INTRODUCTION 
1.1 MICROBES 
The vast array of intestinal bacteria (gut microbiota), which weigh 1-2 kg in an adult human is 
currently estimated to contain 100 trillion members of 40,000 bacterial species belonging to 
1800 genera. These numbers are astonishing, meaning that there are 150-fold more bacterial 
than human genes in the human intestinal lumen (1, 2). The term microbiome is used to describe 
all constituents of these microbiota including genes, proteins and metabolites (3).  During the 
course of evolution gut bacteria ceased acting as prey and began helping to break down 
otherwise undigestable molecules. This role appear to have become more diverse and complex 
in the more advanced compartmentalized gastrointestinal tracts of mammals than in the 
relatively simple tube of the ancient cyclostomatida (4, 5). 
The gut microbiota of invertebrates contains small number of species than in vertebrates. 
Invertebrates have no adaptive immune system and it has been proposed that the expansion of 
microbiota in vertebrates could have occurred as a result of the ability of the adaptive immune 
system to recognize and remember specific microorganisms. Despite significant interindividual 
variation in the composition of the microbiota of different genera and strains, this composition 
appears to be conserved within a given species (Figure 1.1). For example, the microbiota 
communities of humans are dominated by the two bacterial phyla Firmicutes and Bacteroidetes 
with smaller contribution from Actinobacteria and Proteobacteria (4, 6). The mouse is highly 
similar to humans both at the taxonomic and genetic levels (99% shared genes with humans), 
so that findings on murine host-microbiota interactions should be applicable to humans (4).   
An estimated 80% of the bacterial species in the mammalian colon have yet to be cultivated, 
although advances in metagenomic now allow such characterization without the need for 
culturing. Diet help shape the microbiota community: the diversity increases from carnivory to 
omnivory to herbivory (7) and changes in diet lead to shift in the composition. For instance, 
adding fiber to the diet of dogs increases the number of Firmicute bacteria (8).  
Furthermore, obesity influences the composition of the gut microbiota.  Thus, most people 
living in the United States possess a gut microbiota adopted to and capable of digesting a high-
fat, high-protein diet; whereas those living in rural Malawi and the Amazona region of 
Venezuela have distinct microbial consortia optimized for the breakdown of complex 
carbohydrates. Interestingly, in some occasions and in response to a change in diet the gut 
microbiome does not only alter its composition, but also change its genetic make-up via 
horizontal gene transfer. For example, the gut of certain Japanese harbors the bacterium 
Bacteroides plebeius, which bears a gene transferred horizontally from the marine bacterium 
Zobellia galactanivorans that enables seaweed polysaccharides to be degraded. In addition to 
diet, the composition of the gut microbiota is also influenced by the genotype, social group, 
medical history, and advanced age of the host (5, 9). 
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Figure 1.1 The composition of the microbiota across species. Although there can be significant 
interindividual variation, there are general trends within a given species, particularly at the 
phylum level. Different phyla are represented by different colors, and the relative abundance 
of the lower taxonomic levels indicated by font size (4). 
1.1.1 Interactions between gut microbiota and the host 
Accumulating evidence reveals that the gut microbiota plays a major role in promoting health, 
as a result of which it is often referred to as the ‛forgotten organ’(10).  The relationship between 
the host and microbiota is symbiotic and mutualistic, each deriving benefits from the other. 
These two terms are similar but mutualism is defined as ‛an interaction between species that is 
beneficial to both of them’ and symbiosis as ‛the living together of two organisms in close 
association’(11). While the host provides the microbiota with a protected and nutrient-rich 
environment, the microbiota enhance, e.g., digestion, immunity and neuronal development.   
This symbiotic partnership has led to the concept of holobiont, i.e., the host and all its associated 
microbiota. Since such mutual association not only involves sharing biological and chemical 
needs, but also genetic information, the concept of the hologenome defined as the sum of the 
host genome and associated microbiota has emerged (Figure 1.2). The genetic wealth of the 
microbiota is thought to contribute to the holobiont's fitness (adaptation, survival, development, 
growth and reproduction) (12, 13).  
The hologenome theory of evolution proposed by Zilber-Rosenburg and Rosenberg (2007) 
states that natural selection favors not a single organism, according to traditional Darwinism, 
but rather the holobiont with its hologenome (12, 14).  Thus, drosophila prefer to mate with 
other flies raised on the same diet (e.g. starch) and this mating preference is eliminated by 
antibiotic treatment, indicating that the fly microbiota might be involved (15, 16).   
Furthermore, Brucker and Bordenstein (2013) demonstrated that the microbiomes of individual 
wasps of closely related  Nasonia giraulti and Nasonia longicornis  species were more similar 
than that of the more distantly related Nasonia vitripennis. Moreover, dysfunctional 
interactions between the microbiomes formed by crosses of N. vitripennis with N. giraulti 
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resulted in the death the of hybrid larvae. Remarkably, when these hybrid larvae were reared 
on a bacteria-free diet, they survived and exhibited almost normal fitness (17). 
     
        Figure 1. 2 The concept of hologenome. Modified from (13) and (14). 
 
The term commensal, also used to describe the microbiota, means harmless and ‛eating at the 
same table’, i.e., one organism benefits without affecting the other, which is not the case with 
the host-microbial relationship (11). The mutualistic/symbiotic interaction between the 
microbiota and host requires both that the microbes colonize and persist in the host and that the 
host’s immune system can tolerate and control them (18). Disruption of this tight relationship 
(dysbiosis) has been related to a spectrum of diseases, including non-alcoholic fatty liver 
disease, diabetes, hypertension, inflammatory bowel disease, colon cancer, allergies, asthma 
and, very recently, even neuropathologies (19).  
1.1.2 Functions of the gut microbiota 
The most extensive microbial population is present in the large intestine, where it confers many 
benefits on the host, including pathogen displacement, development of the immune system, 
barrier fortification, production of vitamin and absorption of nutrients.  These microbiota are 
key factors in maintaining homeostasis, with functions affecting virtually every organ in the 
body, e.g., regulation of bone mass, brain development and behavior, hepatic function, and 
aspects of adipose tissues and the cardiovascular system (Figure 1.3).   
Recent studies also point to the involvement of the microbiota in the development of 
personalized medicine and in xenobiotic metabolism. Certain environmental toxins and drugs 
are metabolized by the gut microbiota into less or more harmful substances.  Several biological 
active compounds are also produced by the gut microbiota such as short chain fatty acids 
(SCFAs), conjugated linoleic acid, phenoles, indoles, or trimethylamine (3). 
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                      Figure 1.3. Microbial impact on host physiology. Modified from (20) and (21).                    
1.1.3 Short chain fatty acids (SCFAs) 
Among the signaling molecules produced by the gut microbiota that could affect host 
physiology are the short-chain (1-6-carbons) fatty acids (SCFAs) such as butyrate, acetate and 
propionate that arise from the fermentation of fibers (22). Bacteria of the Bacteroidetes phylum 
(e.g., Bacteroidetes thetaiotamicron) produce large amounts of acetate and propionate; whereas 
bacteria of the Firmicutes phylum (e.g., Clostridium tyrobutyricum) produce large amounts of 
butyrate. In this context, the most abundant SCFA is butyrate (C4), followed by acetate (C2) 
and propionate (C3) (22).   
Butyrate, the major fuel for colonocytes, appears to participate in the regulation of intestinal 
cell growth and differentiation (22);  increases the expression of tight junction proteins (TJPs) 
in vitro (23); and induces angiogenesis in the small intestine in vivo (22). Acetate and 
propionate are transported to the liver and peripheral organs, where they act as substrates for 
gluconeogenesis and lipogenesis.  In addition to providing energy, SCFAs have been 
implicated in regulation of the intestinal immune system (affecting the oxidative burst, 
degranulation and phagocytosis (24)), as well as in promoting mineral absorption, mucin 
production, and the expression of antimicrobial peptides (25).   
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SCFAs enter cells both by simple diffusion and through the action of transporters of 
monocarboxylates and other solutes. Butyrate and propionate, but not acetate control gene 
expression by inhibiting histone deacetylase (HDAC), resulting in hyperacetylation of both  
histones and non-histone proteins (26). All three of these SCFAs can also activate cells through 
G-protein-coupled receptors (GPCRs), such as GPR41 or GPR43, with differing ligand 
specificities and potencies.  Propionate is the most potent activator of both GPR41 and GPR43; 
acetate has higher affinity for GPR43; whereas butyrate activates GPR41 more potently (27).   
Activation of GPR41 and GPR43 by SCFAs stimulates secretion of peptide YY, which slows 
down gastrointestinal transit.  Stimulation of GPR43 by SCFAs is crucial for the regulation of 
energy balance and adiposity and in adipocytes, signaling via GPR41 induces lepitn secretion 
and elevates adipogenesis (28). Moreover, signaling via GPR43 has anti-inflammatory effects 
as reflected in the observation that GPR43-kockout (Gpr43-/-) murine models of colitis, arthritis 
and asthma display exacerbated or unresolved inflammation (29). 
Exposure to metabolites produced by the gut microbiota, such as SCFA, begins already in utero 
and may contribute to developmental programming and susceptibility to disease development 
later in life.  
1.2 MICROBES AND DEVELOPMENTAL PROGRAMMING 
The prenatal period is the most important and critical phase of mammalian development, 
preparing the fetus for postnatal life.  Exposure to environmental stimuli during this sensitive 
and vulnerable period could be detrimental to adult health.  For instance, there is now much 
evidence that a nutrient poor in utero environment due to a poor maternal diet or placental 
insufficiency ‘programs’ the fetus in such a way as to enhance the risk of developing 
cardiovascular and metabolic diseases later in life.  Moreover, convincing epidemiological and 
experimental findings support a strong association between maternal undernutrition or fetal 
overexposure to stress-related hormones such as the glucocorticoids and subsequent risk of 
developing a number of pathologies as an adult, such as diabetes, hypertension, obesity, 
immune dysfunction, and behavioral problems (30, 31). Such pathological conditions 
undoubtedly affect the quality of life and, ultimately, reduce life expectancy. Accordingly, if 
organ systems are indeed programmed earlier interventions designed to correct developmental 
defects should be more effective than later interventions.  
1.2.1 The concept of developmental programming 
The concept of developmental programming was first proposed by Barker as the ‘fetal origin 
of adult disease’, i.e., a correlation between poor fetal environment and later risk for disease 
(32).  However, the realization that human development continues postnatally, influenced 
primarily by the composition of and nutrition in breast milk, led to a change in terminology to 
the ‘developmental origins of health and diseases (DOHaD)’ (33). The relative contribution of 
genes and environment to the association between early life experience and later health is still 
the subject of intense debate.   
In 1962, the geneticist James Neel put forward the ‛thrifty genotype’ hypothesis in an attempt 
to explain the relatively high incidences of obesity and type 2 diabetes mellitus (T2DM) among 
certain ethnic groups (34, 35).  This hypothesis postulates that evolutionary exposure of 
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humans to food scarcity and famine selected for “thrifty genes” designed to maximize 
metabolic efficiency and searching for food. In modern-day societies in which food is abundant 
and the life-style sedentary, these genes predispose to diseases caused by excess caloric intake, 
such as obesity and insulin resistance (34).  
The thrifty genotype hypothesis is often cited alongside the ‛thrifty phenotype’ hypothesis 
proposed 30 years later by Hales and Barker (1992), who suggested that fetal response to 
energy insufficiency induces a thrifty phenotype characterized by insulin resistance and  a shift 
in the circulation to protect the growth of vital organs such as the brain and heart at the expense 
of other tissues such as muscle, the liver and the endocrine pancreas (36, 37).  Such adjustment 
and growth plasticity enhance immediate fetal survival, but elevate the subsequent risk of 
developing metabolic diseases caused by nutritional excess and consequent weight gain (36). 
This hypothesis might explain, at least in part, why the incidences of metabolic and 
cardiovascular diseases are very low in areas of Africa where poor foetal nutrition is followed 
by poor postnatal nutrition and high physical activity, while these incidences are strikingly 
higher among individuals in these same areas who move from rural regions to urban areas with 
better nutrition and less physical activities (38).   
Evidence from human studies supports this thrifty phenotype hypothesis. First, men and 
women exposed in utero to food shortage (the Dutch famine) at the end of the Second World 
War exhibit poorer glucose tolerance than those not exposed to the famine (39). Secondly, 
growth-restricted (or small-for-gestational-age) babies born to mothers who smoked during 
pregnancy are more prone to develop obesity and T2DM (40).  And thirdly, among 
homozygotic twins, the twin with the lowest birth weight is more likely to develop diabetes 
(41).  Experimental data from animal studies also provide strong support for this hypothesis 
(42). 
Concerning the thrifty genotype hypothesis certain mutations (e.g., in the gene encoding 
glucokinase that result in insulin resistance) have been associated with low birth weight and 
later development of T2DM (43). However, such mutations appear to be rare, indicating that 
the environment also makes a substantial contribution in this connection (38).     
At first glance, the ‘thrifty genotype’ and ‘phenotype’ hypotheses may appear to be in conflict. 
In fact, the ‘thrifty genotype’ describes long-term effects of selection on a population, whereas 
the ‘thrifty phenotype’ concerns the adaptive nature of offspring, including their plasticity 
during early development (44). (The term ‛developmental plasticity’ refers to permanent 
influence of environmental conditions encountered during development on a trait (33)).  
The ‘thrifty phenotype’ hypothesis is more widely accepted and several proposals concerning 
such adaptive developmental plasticity have emerged in recent years (reviewed in (44)).  One 
model proposes that foetal adjustments to the prenatal environment are not designed merely to 
improve immediate survival, but rather a ‘predictive adaptive response’ meant to promote 
survival during reproductive life.  The metaphor used in this context is the weather forecast: 
the developing organism responds adaptively to information gained via the placenta or during 
lactation to make a forecast concerning the external environment in which it will later grow 
and, in particular reproduce (44-46).  
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1.2.2 Gut microbiota and developmental programming 
 
Since microbial colonization of mammals controls a variety of physiological functions in the 
host, early alterations in this colonization might influence the risk of developing diseases later 
in life. Initial microbes are provided in utero by the maternal microbiota and influenced 
thereafter by the mode of birth and type of infant feeding and exposure to antibiotics (47, 48). 
Consequently, the microbiota is heterogeneous and unstable until approximately 2–4 years of 
age, when it becomes more stable and begins to resemble the adult microbiota (49). 
 
Experimental, clinical and epidemiological findings indicate that early microbial colonization 
during pregnancy and birth may exert a long-lasting impact on the risk of developing allergic, 
autoimmune and metabolic diseases in adulthood.  For example, exposure of a pregnant woman 
to farm animals, which presumably leads to more extensive fetal contact with microbes  
protects the infant from immune-mediated conditions such as asthma and eczema.  Such 
observations forms the basis for the ‛hygiene hypothesis’, which states that a relative lack of 
microbial exposure due to the hygienic conditions in developed countries hampers proper 
maturation of the immune system, thereby predisposing individuals to allergies and 
autoimmune diseases (50). This hypothesis also fits well with the concept of developmental 
programming discussed above. 
In animals, raising the fiber content of the maternal diet during pregnancy and lactation caused 
specific alterations in the pup’s microbiota, including populations enriched in  Bifidobacterium 
spp and Lactobacillus spp (51). Maternal administration of antibiotics exerted enhanced 
permeability and systemic inflammation in the offspring (52), while interestingly 
supplementation of the maternal diet with the probiotic bacterium Lactobacillus plantarum 
restored intestinal permeability and stimulated the growth of the offspring’s intestine (52). 
These later responses occurred only in rats exposed to this probiotic bacterium early between 
postnatal days 3 and 10 (53), emphasizing the early window of action. 
The role of gut microbiota in the developmental programming of the rodent brain, influencing 
both brain chemistry and behavior has been documented in several recent reports (54-56) For 
example, germ-free (GF) mice display less anxiety (54, 55) and more motor activity (54) than 
animals free from specific pathogen  (SPF). Notably, the behavior of GF mice could only be 
normalized when they were colonized prenatally (i.e., through the mothers) (54).  
1.2.3 The placenta and developmental programming 
The placenta evolved to support fetal growth and its role in nutrient transfer is pivotal with 
respect to developmental programming. Defects in placental development cause growth 
restriction preceded by impairment of placental nutrient transport (57). Available evidence 
reveals the remarkable ability of the placenta to ameliorate, rather than exacerbate, the 
influence of environmental cues involved in developmental programming.  
Initially, the placenta adapts to changes in the maternal environments by optimizing nutrient 
and gas transport to promote survival of the fetus. Resorption or abortion occurs only under 
the most extreme conditions, i.e., when the life of the mother is threatened (58). Although 
maternal illness, such as diabetes and pre-eclampsia, exert profound effects on placental 
development, there is growing evidence that the placenta is also affected by more subtle 
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signals related to maternal nutrition, body composition and life-style (e.g., exercise, smoking 
and alcohol intake) (57, 59). Placental adaptations to such insults include alterations in 
vascularization, thickness of the placental barrier, the expression and activities of key 
transporters of nutrients and epigenetic modifications of  genes (60). To date, few 
experimental or epidemiological studies addressing the thrifty phenotype hypothesis have 
considered the placental contribution to developmental programming, which must be 
understood if efficient interventions are to be developed in the near future.  
1.3 MICROBES AND THE PLACENTA 
While the present dogma is that the mammalian embryo/fetus lives in a sterile environment as 
a result of the placenta barrier, it has become clear that bacteria are naturally present in cord 
blood (61) and meconium (62). Indeed, the placenta itself appears to harbor a unique 
microbiome (63). Consequently, it is of the utmost importance to examine the impact of 
interaction between the maternal microbiome and the placenta on health. 
1.3.1 The mammalian placenta 
 
The placenta, a transiently vascularized chimeric organ composed of both maternal and fetal 
tissues, is used by all mammals for reproduction, with the exceptions of monotremes (egg-
laying mammals) such as the duck-billed platypus and four species of echidna (also known 
as spiny anteaters). The word placenta, derived from the Latin word for ‘flat cake’, was 
introduced in the sixteenth century by the Italian anatomist Renaldus Columbus (64, 65).  
Throughout history this organ held a place of honor and is, indeed, considered sacred in many 
cultures and societies. In ancient Egypt, the placenta was believed to be one of the gods and 
was paraded before the Pharaoh during royal processions (Figure 1.4) (64, 65).  In other 
cultures, this organ is viewed as the older sibling and is buried ritually by the mother.  In 
modern culture, the placenta is usually discarded,  used for research or even sold as a cosmetic 
product (64).  
 
Figure 1.4. The placenta (far left) depicted in ancient Egypt as an organ with two lobes 
attached to the umbilical cord. 
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The placenta, unique in connecting two genetically distinct organisms, delivers nutrients and 
oxygen from the mother to the fetus and also adapts maternal metabolic, endocrine, 
cardiovascular and immune functions to promote fetal growth and survival.   Although long 
considered to be merely a passive transporter of maternal resources and fetal waste, advances 
in imaging technology and immunological methodology have revealed that the placenta 
produces a wide array of signalling molecules (hormones, cytokines, molecules that influence 
immune function and, indeed, all other classes of signaling molecules), that act both locally 
and at a distance. The placenta  has been referred to appropriately by the late and eminent 
reproductive endocrinologist Samuel Yen as the ‛third brain’ of pregnancy (Yen 1994) (66). 
The placenta has a substantial capacity to respond to the intrauterine environment, while the 
fetal brain is immature (64). 
1.3.2 Anatomy of the human and murine placenta 
 
Despite the huge variation in placental development among mammals, the placentas of 
humans and mice share a number of structural, cellular and molecular features, as described 
extensively in several reviews (67, 68) . In both species, the placenta is divided into three 
regions: 1) The region proximal to the fetus, termed the labyrinth in mice and chorionic villi in 
humans, is specialized for the exchange of nutrients and gases containing fetal and maternal 
blood vessels.  The tree-like branches in this region of human placenta provide a large surface 
area for exchange. On the other hand, in the murine the branches are much more interconnected, 
generating a maze-like pattern or labyrinth (67, 69, 70).  
 
2) The middle layer consists of densely packed trophoblast cells, referred to as cytotrophoblast 
cell columns and the spongiotrophoblast layer in humans and mice, respectively. The precise 
function of this layer is unknown, although its integrity is absolutely vital to fetal survival. It 
may provide support for the underlying labyrinth/villi, although in mice spongiotrophoblast 
cells are known to secrete several polypeptide hormones (67, 69).  Also in mice, the 
spongiotrophoblast layer contains another type of cell known as trophoblast glycogen cells, 
which provide substantial energy, especially during late gestation (67, 71). Unlike the labyrinth, 
the spongiotrophoblast layer does not contain any fetal blood capillaries, but it is traversed by 
maternal blood channels (the central artery and lateral veins) (67, 72).  
 
3) The decidua, the outer layer of the placenta bordering the maternal side consists of cells that 
invade maternal blood vessels and have been designated as extravillous cytotrophoblasts and 
trophoblast giant cells in humans and mice, respectively (67).  Under the influence of steroid 
hormones, primarily progesterone, uterine stromal cells are transformed into large secretory 
decidual cells. This process, known as decidualization, is characteristic of species with 
hemochorial placentas (including humans and mice) and is an essential prerequisite for 
implantation (64). In mice, embryo implantation induces decidualization; whereas in humans 
signs of decidualization are present as early as day 23 of the normal menstrual cycle and if 
fertilization does not occur the transformed uterine tissue is shed during menstruation (64, 68).  
In humans, trophoblast invasion normally extends up to, but not beyond, the inner third of the 
myometrium (The muscular wall of the uterus), whereas in mice trophoblasts do not invade 
into the myometrium (67, 68). A schematic illustration of the human and murine placenta is 
shown in Figure 1.5. 
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Figure  1.5.  Comparative  anatomy  of  the  human  and  murine  placentas.  (a)  The  villous 
structure of the human placenta. (b) Cross‐section of trophoblast region of the human uterus 
showing extravillous trophoblasts (EVT) invading the decidua. (c) The labyrinth structure of 
the murine placenta (d) The spongiotrophoblast (SpT) region and trophoblast giant cells (TGC) 
(analogous to EVT) in the murine placenta (73). 
1.3.3 The placental barrier 
 
The placenta forms a barrier that protects the fetus from pathogens, drugs and xenobiotics, 
acting as a so called “fetal armor” (74). Moreover, the placenta aids the fetus in peroids of 
acute maternal starvation by breaking down its own tissue (placental autophagy) in an attempt 
to nourish energy-demanding organs such as the fetal brain (75). Actually, Bonnin and 
colleagues (2011) have proposed  a novel direct role for the placenta in modulating fetal brain 
development by converting maternal tryptophan into the neurotransmitter serotonin (76).  
 
While the placenta promotes fetal survival by maintaining appropriate physiological condition 
in the uterus (67), it also functions as an immunological barrier that prevents the fetus from 
being rejected by the maternal immune system. Many mechanisms have been invoked to 
explain this fetomaternal tolerance, including the expression of non-classical MHC molecules 
by trophoblast cells, tryptophan catabolism by Indoleamine 2,3-dioxygenase, T-cell apoptosis, 
and the complement system (77). The placental barrier in rodents and humans is formed by a 
continuous layer of fused multinucleated fetal trophoblasts known as syncytiotrophoblasts 
(SYN) (67, 73, 78). This is quite different than other nutritive and protective epithelial (e.g., 
the intestine and testis) and endothelial (e.g., the brain and retina) barriers in mammals, which 
are composed of individual cells tightly linked.   
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A growing body of evidence indicates that this unique structure of the SYN provide extensive 
protection, resisting infection by diverse pathogens such as Listeria monocytogenes (79) and 
the protozoan parasite Toxoplasma gondii (73). In addition, in cultures of placental cells 
cytomegalovirus (CMV) infects cytotrophoblasts, but not SYN, and the herpes simplex virus 
(HSV) can only infect if the overlaying SYN is damaged (73).  In humans, the SYN also secrets 
hormones such as estrogens and progesterone required for the maintenance of gestation and 
fetal well-being. In mice, however, these two hormones continue to be secreted by the corpus 
luteum in the ovary, so that ovariectomy results in termination of murine pregnancy (68, 80). 
Interestingly, towards the end of pregnancy when fetal demands are greatest, the placental 
barrier (SYN) layer decreases in thickness to facilitate exchange of materials between the 
mother and fetus (81, 82).  
  
Although they are both hemochorial (i.e., maternal blood comes in direct contact with the 
trophoblasts), the human and murine placental barriers differ in structure.  The human barrier 
involves a single layer of SYN, wherase the murine placental barrier is composed of three 
layers, the outer layer, which consists of mononuclear trophoblast cells (cytotrophoblasts) 
bathed directly by maternal blood (trophoblast Layer I), while both inner layers (trophoblast 
Layers II and III) are multinucleated and syncytial in nature (67, 78, 83) (Figure 1.6). 
 
               
 
 
 
 
 
 
 
 
           Figure 1.6. The structure of the placental barrier in mice. Modified from (84). 
1.3.4 Metabolic changes during pregnancy. 
Pregnancy requires exceptional amount of energy and mammals have evolved regulatory 
endocrine systems that respond to alteration in maternal nutritional status.  Many homeostatic 
parameters are adjusted during gestation, e.g., the circulating levels of glucose, insulin, cortisol 
and leptin are all elevated; adaptive changes designed to ensure the supply of sufficient 
nutrition to the fetus.  For example, maternal insulin resistance in the third trimester is 
considered to be a physiological event, favoring the transport of maternal glucose, the sole 
source of this vital carbohydrate to the growing fetus (64, 85).  
  12
During the early phase of pregnancy, maternal metabolism is anabolic leading to larger 
maternal fat depot and minor enhancement of insulin sensitivity, i.e., storage of  nutrients to 
meet fetal and maternal demands during late gestation and lactation. In the later part of 
pregnancy, maternal metabolism becomes catabolic in order to support the growth spurt of the 
fetus with reduced insulin sensitivity (86) and enhanced maternal hepatic gluconeogenesis, 
lipolysis and ketogenesis (87) (referred to as controlled “accelerated starvation”). The 
attenuated insulin-mediated utilization of glucose promotes maternal use of lipids as an energy 
source, sparing other fuels such as glucose and amino acids for fetal use (87). 
1.4 MICROBES AND GLUCOCORTICOIDS (GC) 
 
Glucocorticoids (GC), steroid hormones produced predominantly by the adrenal cortex, 
mediate a variety of physiological processes, including regulation of energy metabolism and 
suppression of inflammation. The more nuanced role of GC in response to stress promotes 
homeostasis and is beneficial for short-term survival and recovery from challenge. On the other 
hand, long-term exposure to high levels of GC can lead to serious metabolic, immune and 
psychological dysfunctions (88).  
 
Accordingly, the secretion of GC is under efficient feedback control by the hypothalamo-
pituitary-adrenal (HPA) axis (88). Physiological and psychological stressors potently activate 
hypothalamic secretion of the corticotropin-releasing hormones (CRH) that induces the 
anterior pituitary gland to release adrenocorticotrophic hormone (ACTH), which then 
stimulates GC synthesis in the adrenal cortex. GC itself  functions as a negative feedback 
signal, inhibiting the release of both CRH and ACTH (89).   
 
The major GC in humans is cortisol, while in rodents, which lack the 17α-hydroxylase 
required for hydroxylation of pregnenolone to produce cortisol, corticosterone is present in 
highest levels. The equilibrium between biologically active and inactive forms of the GC is 
determined by two isoenzymes of 11β-hydroxysteroid dehydrogenase (11β-HSD): in humans, 
type 1 (11βHSD1) converts inert cortisone into active cortisol (that can bind and activate GC 
receptors), while metabolism of cortisol to inactive cortisone is catalyzed by both type 1 and 
type 2 (11βHSD) (90) (Figure 1.7). 
 
 
 
 
 
 
 
 
 
Figure 1.7. Cortisol‐cortisone  inter‐conversion by hydroxysteroid dehydrogenase  (11βHSD) 
enzymes type 1 and 2 (90). 
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The glucocorticoid receptors (GRs) belong to the superfamily of nuclear receptors and are 
classified into three subtypes, α, β and γ. Upon binding hormone, the GR-α dimer translocates 
from the cytoplasm into the nucleus, where it associates with specific glucocorticoid response 
elements (GREs) on DNA to trigger the transcription of target genes (90, 91). GRs are 
ubiquitously expressed and necessary for survival, as reflected in the finding that mice which 
lack GRs are not viable (91). 
 
A decade ago Sudo and co-workers (92) showed that in the absence of microbiota the HPA 
axis develops abnormally, leading to exaggerated responsiveness to stress and elevated 
corticosterone levels. It is noteworthy that bacterial colonization of GF mice after weaning did 
not alter this change in the HPA axis indicating the occurrence of a critical window of time 
very early in life (92).  In contrast, probiotic supplementation of the dams during pregnancy 
and lactation normalized the levels of corticosterone and CRH in neonates separated from their 
mothers (93).  The basal level of corticosterone in the absence of stress is higher in GF mice 
and mice exposed to antibiotic than in animals raised conventionally (94).  The mechanism by 
which the microbiota influences the HPA axis has yet to be determined. 
1.4.1 Glucocorticoids and metabolism 
 
The term “glucocorticoids” derives from early observations on the involvement of these 
compounds in regulating glucose metabolism. GC is diabetogenic, elevating blood levels of 
glucose by opposing the action of insulin in peripheral tissues, mainly through a reduction in 
glucose uptake via GLUT4 receptors and elevated hepatic gluconeogenesis.  Therefore, excess 
GC exerts anabolic effects on the liver and catabolic effects on muscle and fat decreasing 
lean body and muscle mass and increasing energy expenditure. At the same time, GC lead to 
greater fat mass by enhancing appetite (91).  
 
In the case of the liver, elevated levels of GC promote lipogenesis by increasing the 
production of low-density lipoprotein (VLDL) and triglycerides (TG) thereby triggering 
hepatic fat accumulation (steatosis) and high blood levels of lipid. In the case of fat, GC 
promote lipolysis and reduced free fatty acids (FFA) uptake in the peripheral depots, while 
inducing hypertrophy and differentiation of adipose cells in central depots thus leading to 
abdominal obesity and insulin resistance (91). Thus, insulin resistance, fatty liver, increased 
breakdown of skeletal muscle mass and hyperglycemia occur in patients with Cushing’s 
syndrome, a disease characterized by hypersecretion of GC by pituitary adenomas or ectopic, 
ACTH-producing tumors (91). It was recently shown that the hyperglycemia, insulin 
resistance, and hypertension triggered in wild-type mice by GC are not observed in animals 
lacking the nuclear receptor peroxisome proliferator-activated receptor (PPAR)α (95). 
Remarkably, selective cutting of the vagus nerve attenuates the PPARα-dependent metabolic 
dysfunction induced by GC, improving insulin sensitivity and reducing glucose levels (96). 
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1.4.2 The influence of glucocorticoids on fetal and placental development. 
 
GC are essential for normal fetal development, including maturation of the fetal liver, lungs, 
gut, skeletal muscle and adipose tissue in preparation for extra-uterine life. Their levels rise 
during late pregnancy, stimulating the lung to produce surfactant in preparation for extrauterine 
life. Thus, synthetic GC are effectively administered to preterm infants in whom pulmonary 
immaturity threatens viability, although the treatment is not without negative side-effects (88, 
97, 98).  
 
GC modulate a variety of developmental processes, from embryo implantation to subsequent 
growth of the fetus and placenta.  For example, GC regulate uterine synthesis of prostaglandins, 
which play important roles in implantation and the initiation of labor. Moreover, synthetic GC 
(dexamethasone and triamcinolone) stimulate the secretion of chorionic gonadotrophin (hCG) 
by human term trophoblasts 10-fold.  GC are also involved in preventing immunological 
rejection of the fetal semiallograft by inhibiting eosinophil infiltration. Another 
immunosuppressive effect of GC involves suppression of uterine natural killer (uNK) cells, 
which have been implicated in recurrent miscarriages (90, 98).   
 
In summary, appropriate exposure to GC in utero is critical for fetal organ development, but 
excess levels are detrimental and may predispose to diseases such as hypertension, diabetes 
and stroke later in life.  Such overexposure exerts adverse effects on the development of the 
fetal brain and enhances the post-natal activity of the HPA axis (90). For example, treatment 
of pregnant rats with dexamethasone altered post-natal learning and cognitive functioning in 
the pups, whose cholinergic neurons were also abnormally sensitive to neurotoxins (99). In 
addition, elevation of GC levels in pregnant rats by pharmacological blocking of the feto-
placental 11βHSD2 activities, the physiological "barrier" to maternal GC, impaired post-natal 
behavior and expression of hypothalamic GR by the offspring (100). Likewise, the offspring 
of transgenic mice lacking the 11βHSD2 exhibit abnormally high anxiety (101).  
 
Moreover, exposure of non-human primates (marmoset monkeys) to dexamethasone during 
early or late pregnancy impaired proliferation of dentate gyrus cells without affecting their 
differentiation (102). Few long term follow-up studies on preterm children who received 
antenatal GC, have been reported, some showing an effect on behavior (103, 104), but others 
not (105-107). Recently, an association between prenatal exposure to synthetic GC and mental 
health in children and adolescents, was found (108), but the number of participants in this study 
was small.  
 
The above effects of GC on the fetus are mediated, at least in part, via effects on placental 
growth and function. In a number of  animal species and in humans as well, exposure to 
elevated GC during pregnancy reduces placental weight to an extent dependent on the timing 
and duration of exposure as well as the dose and type of GC  (98, 109).  In rodents elevated 
exposure to GC compromises placental growth by promoting trophoblast apoptosis (110) and 
attenuating IGF2 expression (111), processes that are actually more sensitive to GC than fetal 
growth. Moreover, administration of synthetic GC to the pregnant dams restricts placental 
vascular development by inhibiting vascular endothelial growth factor (VEGF) and 
downstream activation of PPARγ (112, 113). In a similar manner  the placentas of asthmatic 
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women taking high doses of GC display hypovascularized fetal villi with reduced placental 
blood flow (98).  
 
In addition, the thickness of the placental barrier thickness and its capacity to transport glucose 
and amnio acids are influenced by maternal GC treatment. In mice, dexamethasone reduced 
the thickness of the area of diffusion in the labyrinth zone and concurrently elevated the surface 
area for nutrient exchange (98). In trophoblast cells, GC downregulate GLUT1 and GLUT3 
expression in vitro (109) and injection of GC into the rat placenta, lowers the levels of both 
GLUT1 and GLUT3 transcripts and proteins (98).  
 
The placenta actively protects the fetus from overexposure to GC by metabolizing these 
compounds via 11βHSD2, which is expressed by the syncytiotrophoblasts and converts cortisol 
and corticosterone to inactive metabolites (although many synthetic GC are metabolized poorly 
by this enzyme).  As a result, maternal cortisol/corticosterone levels are as much as 10-fold 
higher than those in fetal blood depending, on fetal age. Indeed, inhibition of 11βHSD2 during 
pregnancy retards fetoplacental growth and lead to abnormalities in cardiovascular and 
metabolic functions in the adult offspring (97).  
 
1.5 MICROBES AND CONTROL OF BARRIERS  
In specialized compartments of the body, movements of molecules between the blood and cells 
in tissues are hindered by so-called gatekeepers. Such blood-tissue barriers were first described 
about 100 years ago in pioneer experiments showing that dyes administered to laboratory 
animals failed to stain the testis and the brain (114-116), leading to the concepts of the blood-
brain barrier (BBB) and the blood-testis barrier (BTB). These two barriers are considered the 
tightest in the body, but differ in structure and function.   
1.5.1 Comparison of the BBB and BTB 
The BBB is formed by TJPs between endothelial cells lining the blood vessels, whereas the 
BTB is the result of TJPs between epithelial cells referred to as Sertoli cells (117) and 
consequently Russell and Peterson (1985) coined the term ‘Sertoli blood barrier’ for the BTB 
(118). Another fundamental difference is the organization of the TJPs: In the brain, these 
junctions are localized only at the apical surface of the endothelium, sealing the intercellular 
space with adherens junctions (AJ) immediately below the tight junction fibrils. In the BTB, 
on the other hand, TJPs coexist with basal ectoplasmic specializations (basal ES) and basal 
tubulobulbar complexes (basal TBC) (of which both are testis-specific, actin-based adherens 
junctions) and the desmosome-like junctions (Fig. 1.8) (117, 119). 
Nevertheless, the TJPs that form these two barriers display remarkable molecular similarities, 
both being formed by strands of occludin, JAM, and claudin molecules linked to the 
cytoskeleton through the zonula occludens (ZO-1, ZO-2 and ZO-3) (119). In knock-out mice, 
loss of claudin-5 leads to disruption of the BBB (120) and lack of occludin is associated with 
calcification of the brain with no change in the permeability of the BBB (121).  In the testis, 
loss of occludin, claudin-3 and 11, the dominant forms there, disturbs spermatogenesis and 
causes sterility (116, 122, 123). Moreover, under pathological conditions such as stroke (124), 
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multiple sclerosis (125) and Alzheimer disease (126) (where the  BBB is disrupted), orchitis 
(127) and male infertility (116) (with disrupted BTB) the TJPs are down-regulated or 
redistributed. Interestingly, diabetes mellitus affects the paracellular and transcelluar 
permeability of the BBB and BTB negatively (128). 
Both barriers physically separate their respective organs into apical and basal compartments 
exerting strict control over the transfer of ions and molecules.  The BTB develops postnatally 
in rodents and during puberty in humans (119), while the BBB is formed prenatally in both 
rodents (129) and humans (130).  Both barriers create ‛immune-privileged sites’, i.e. tissue 
transplanted into the brain (131) or the interstitial space of the testis (127) is not rejected.  
This ‘privilege’ is due to the absence of draining lymphatic vessels and an almost complete 
lack of circulating immune cells, which are prevented from entering by the BTB and BBB. 
In the case of the BTB, mature sperm cells (spermatozoa) expressing new antigens that can 
be recognized as ‛foreign’ arise after puberty but these new autoantigens are tolerated and do 
not normally evoke an immune response by the testis (127). From an evolutionary 
perspective, immune privilege is regarded as a protection for vulnerable organs with limited 
capacity to regenerate. While the role of gut microbiota in fortifying the intestinal barrier is 
well documented, its influence on other blood-tissue barriers requires further examination. 
Figure  1.8. A  simplified  diagram  illustrating  the morphological  differences  between  the 
blood‐testis barrier (BTB) and the blood‐brain barrier (BBB). (A) In the BTB, tight junctions 
(TJs)  coexist  with  basal  ectoplasmic  specializations  (ES),  basal  tubulobulbar  complexes 
(TBC), and desmosome‐like junctions. (B) In the BBB TJs are restricted to the apical surface 
of  the endothelium, sealing  the  intercellular space, with adherens  junctions  (AJ)  located 
immediately below (117). 
1.5.2 The blood-brain barrier (BBB) 
As mentioned above, the BBB is formed by TJPs between endothelial cells that line cerebral 
microvessels (Figure 1.9). Small gaseous molecules (O2 and CO2) and small lipophilic agents, 
including drugs such as ethanol, caffeine, nicotine, heroin and methadone, can diffuse freely 
through the lipid membranes of the BBB; whereas hydrophilic molecules such as glucose, 
several amino acids and neurotransmitters must be carried across by specific transporters. Two 
major groups of transporters are involved, i.e., the solute carriers (SLCs) and active efflux 
carriers (ABC transporters), both expressed on the luminal and/or adluminal surface of the 
BBB. Large hydrophilic molecules such as proteins can only be translocated across  
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membranes via endocytosis (receptor-mediated transcytosis or adsorptive-mediated) (132), 
which is however, uncommon in  brain endothelium. The high metabolic demands placed on 
cerebral endothelial cells by active transport are reflected in higher abundance of mitochondria 
than in systemic endothelial cells (133). 
 
 
 
 
 
 
 
 
 
Figure 1.9. The blood–brain barrier (BBB). Molecules cross the BBB either transcellulary or 
paracellularly between the cells through the junctions. Modified from (134). 
1.5.2.1 Development of the BBB 
During embryonic angiogenesis, neural progenitors induce endothelial cells to express BBB-
specific proteins such as TJPs and nutrient transporters. At E13, pericytes then strengthen the 
barrier properties by sealing the interendothelial TJPs, limiting the rate of transcytosis, down-
regulating the expression of leukocyte adhesion molecules and inducing the expression of 
efflux transporters. A functional BBB that excludes tracers administered intravenously from 
the CNS parenchyma is present at E16. Normally, astrocytes appear postnatally to provide 
additional support to the functional  BBB during adulthood, as well as in connection with injury 
and disease (Figure 1.10) (129, 135).   
 
 
 
 
 
 
 
Figure 1.10. Schematic illustration for the time‐course of BBB development. Modified from (129).  
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1.5.2.2 Functions of the BBB 
The many vital roles played by the BBB include supplying the brain with important nutrients, 
mediating the efflux of numerous waste and toxic substances and regulating ion trafficking 
between the blood and brain via specific ion transporters and channels to produce a brain 
interstitial fluid (ISF) of optimal composition for neuronal function. This composition is similar 
to that of blood plasma except that the protein content is much lower, the K+ and Ca2+ 
concentrations are also lower and the level of Mg2+ is higher. Importantly, the BBB protects 
the brain from fluctuations in ionic composition that can occur following exercise or after a 
meal. Furthermore, since immune surveillance in the CNS is limited, the BBB acts as a shield 
against infection and foreign materials (132, 136). 
1.5.2.3 Cell types associated with the BBB 
The brain endothelial cells that form the BBB are surrounded by or closely associated with 
several types of cells, including the perivascular end-feet of astrocytic glia, pericytes, microglia 
and neurons (132, 136) (Figure 1.9). The close association between such cells and brain 
capillaries suggests that they are involved in specific features of the BBB and, indeed, 
transplantation studies have demonstrated that formation of  the BBB is induced by interactions 
between endothelial cells and the neural cells (137). There is now strong evidence, particularly 
from cell cultures, that astrocytes can up-regulate many features of the BBB involved in 
creating effective tight junctions (138).  In addition, pericytes are required for the integrity of 
this barrier both during embryogenesis (129) and in adulthood (139). Thus, the BBB of adult 
mice lacking pericytes is leaky to water and a range of low and high-molecular-weight tracers. 
During development, pericyte–endothelial cell interactions are crucial for the formation of 
TJPs in the BBB, as well as for vesicle trafficking by CNS endothelial cells.  
The possible influence of other cell types on the BBB is less well characterized. Some 
investigations suggest an inductive role for microglia, macrophages derived from blood 
monocytes and resident in the CNS. Accordingly, co-culture of brain endothelial cells with 
blood macrophages enhanced barrier tightness (140). Some indirect evidence indicates that 
smooth muscle cells may also influence BBB functions (141).   
1.5.3 The blood-testis barrier (BTB) 
The BTB is formed by TJPs between two adjacent Sertoli cells at the seminiferous tubules, 
with the peritubular layer of myoid cells that encircle the seminiferous tubules and the testis 
endothelial cells in the interstitium also making a significant contribution  (142, 143) (Figure 
1.11).   The primary functions of this barrier are to segregate the haploid male germ cells 
from the immune system, create polarity and help to create a unique environment for germ 
cell differentiation. At the same time, the BTB poses an obstacle to the development of non-
hormonal male contraceptives by sequestering drugs (e.g., adjudin) in the apical 
compartment (144).   
The BTB forms during puberty in human (at ~ 12-14 years of age), while in mice a functional 
BTB is established ~ 15-16 days after birth (119, 145), which coincides with the time-point 
at which the testis cords are transformed into seminiferous tubules with a lumen (146, 147), as 
well as when the Sertoli cells cease to divide and become terminally differentiated (148). 
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Thus, in adult mammals the number of Sertoli cells is thought to remain relatively constant 
(119, 148), although there are reports that these cells can proliferate and divide in adult rodents 
under experimental conditions (149) and even under physiological conditions in humans (150). 
The number of Sertoli cells determines the number of germ cells that can be supported during 
spermatogenesis and thus sperm production and the sperm count in adulthood (147, 148).  
Sertoli cells are highly dynamic, changing their three-dimensional structure during the course 
of spermatogenesis and spermiogenesis (151, 152).  This causes the BTB to change as well: 
the TJPs undergo remodeling (opening and closing) to allow the passage of preleptotene 
spermatocytes from the basal to the adluminal compartment, where they undergo meiosis 
(151). This structural disassembly and reassembly of the TJPs occurs at stage VIII in the rat 
and is tightly regulated by testosterone and cytokines (153-155).    
Figure 1.11. Schematic illustration of the seminiferous tubule and the blood‐testis barrier 
(BTB). The BTB  is  formed by  tight  junctions between Sertoli cells. Blood vessels and  the 
Leydig cells, which produce testosterone, are located in the interstitial space. Adjacent to 
the  basement membrane  are  several  layers  of modified myofibroblastic  cells,  termed 
peritubular cells (156). 
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1.6 MICROBES AND TESTOSTERONE 
Testosterone produced by the Leydig cells, is essential for male sexual differentiation, 
spermatogenesis, and expression of male secondary sex characteristics.  Its biosynthesis is 
primarily under the control of the pituitary derived luteinizing hormone (LH), which upon 
binding to its receptor on the plasma membrane of Leydig cells,  stimulates formation of  cAMP 
from ATP and cAMP, in turn, activates protein kinase A, which is required for the transport of 
cholesterol from the cytoplasmic pool into mitochondria. Cholesterol transfer from the outer to 
the inner mitochondrial membrane is facilitated by the steroidogenic acute regulatory protein 
(StAR) and peripheral benzodiazepine receptor (PBR) (89, 157).  
The P450 side-chain cleavage (P450scc or CYP11a) enzyme, which resides on the matrix side 
of the mitochondrial inner membrane, converts cholesterol into pregnenolone, which then 
diffuses to the smooth endoplasmic reticulum (SER) for conversion to progesterone by 3β-
hydroxysteroid dehydrogenase ∆5-∆4-isomerase (3β-HSD or Hsd3b).  Progesterone is then 
converted (158) in two steps involving 17α-hydrosylase (17α-OH-lase) and C17-20 lyase to 
androstenedione, which is finally converted to testosterone by 17β-hydroxysteroid 
dehydrogenase type III (17 HSD3) (Figure 1.12). Subsequently, testosterone can be converted 
to estradiol by the P450 aromatase (Cyp19).  Earlier studies revealed that the gut microbiota 
influences testosterone production , but it remains unclear whether this involves regulation of 
the circulating level of pituitary LH  and/or of  Leydig cell steroidogenesis (157).  
 
Figure  (1.12).    Schematic  illustration  of  Leydig  cell  steroidogenesis.  Adenyl  cyclase  (AC), 
steroidogenic acute regulatory protein protein  (StAR),  peripheral  benzodiazepine  receptor 
(PBR),  the mitochondrion  (M),  cytochrome  P450  side‐chain  cleavage  (P450  scc),  smooth 
endoplasmatic  reticulum  (SER),  3β‐hydroxysteroid  dehydrogenase  ∆5‐∆4‐isomerase  (3β‐
HSD), 17α‐hydrosxylase (17α‐OH‐lase), and C17‐20 lyase, 17β‐hydroxysteroid dehydrogenase 
type III (17 HSD3) (157).
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2 AIMS 
 
The overall aim of the present thesis was to characterize host-microbe interactions concerning 
three immune-privileged organs i.e., the placenta, brain and testis. In particular, we evaluated 
the influence of the normal gut microbiota on the developmental programming of these 
organs.  The specific aims were therefore as follows: 
 
I. To determine the role played by the gut microbiota in maternal metabolism during 
pregnancy (Paper I). 
 
II. To investigate the influence of  the maternal microbiome on placental development 
(Paper I). 
 
III. To evaluate the involvement of the gut microbiota in establishing the integrity of the 
blood-placenta, blood-brain and blood-testis barriers (Papers I, II and III). 
 
IV. To characterize the cross-talk between the gut microbiota and its metabolites and the 
brain (Paper II). 
 
V. To assess the influence of the gut microbiota on testosterone production and male 
reproduction (Paper III). 
 

   23
3 METHODOLOGICAL HIGHLIGHTS 
 
Detailed descriptions of the methods employed in this thesis are presented in the individual 
papers.   Therefore, this section will describe the germ-free mouse model utilized in all three 
publications. The advantages and disadvantages of the procedures applied to assess the 
permeability of the three barriers (BPB, BBB, BTB) will also be discussed.  
3.1 GERM-FREE AND GNOTOBIOTIC MICE  
 
GF animals provide an invaluable experimental tool for examining interactions between 
a host and its microbiota. The term germ-free (axenic) refers to an animal demonstrably 
free from microbes including bacteria, viruses, fungi, protozoa and parasites, throughout 
its lifet ime (159, 160).  GF animals selectively colonized with one or more bacterial species 
are referred to as gnotobiotic (161, 162) (a term sometimes used synonymously with GF). 
This term is derived from the Greek ‛gnotos’, meaning “known”, and ‛bios’ or a life with a 
fully defined flora. 
3.1.1 Historical aspects of GF experimentation 
 
The concept of a germ-free animal was recognized more than a century ago by Louis Pasteur 
(1885), although he concluded that bacteria-free existence is impossible. Ten years later in 
1895, Nuttle and Thierfelder at Berlin University produced the first GF animals (guinea pigs), 
which survived for as long as 13 days. However, due to the lack of knowledge concerning 
nutrition, it took 50 more years until the first GF rat colonies were established in the late 
1940s. Subsequently, the first GF mice were successfully developed by Pleasants in 1959 
(159, 160, 163).   
 
The GF animal facility at the Karolinska Institutet, one of the oldest in the world established 
in the 1950s by Professor Bengt Erik Gustafsson, a pioneer in the design of equipment and 
procedures for producing GF rats. Figure 3.1 depicts a stainless steel isolator designed by 
Gustafsson (1959) (164) and located at our previous GF facility.  After moving to a new 
building in the beginning of 2013, we now keep all GF mice in plastic isolators (Figure 3.2).   
 
 
 
 
 
 
 
 
 
 
 
      Figure 3.1.  Gustafsson steel isolator at the GF facility at the Karolinska Institutet.  
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3.1.2 Isolator technology 
 
Isolators provide physical barriers that allow creation of a sterile environment. These devices 
have an air supply, air inlet and outlet, transfer port and arm-length gloves, as well as a special 
tank filled with disinfectant and used for the transfer of mice in and out (Figure 3.3). 
Maintaining an isolator is very laborious work and requires special training.  All manipulation 
of mice and supplies occurs inside the isolator through gloves and sleeves attached to the 
isolator walls.  In terms of potential contamination, the gloves are most vulnerable and the 
most common cause of contaminations were due to holes in the gloves. 
 
 
              Figure 3.2 A Plastic isolator at the GF facility at the Karolinska Institutet. 
 
Bedding, food, water, and equipment, including cages, must first be sterilized (autoclaved) 
and are then put into the isolator through the so-called the sterile lock. Sterilization of entire 
steel isolators is accomplished by autoclaving the whole isolator, as well as with portable 
vacuum and steam equipment. In the case of plastic isolators, which cannot tolerate the heat 
of steam sterilization, sterilization is accomplished with germicidal vapour (2% peracetic 
acid and chlorine dioxide).  Air is sterilized upon entry and exhaust by mechanical filtration 
under positive pressure.  
Figure 3.3 Transfer of mice from inside the isolator. The mouse is placed in an autoclaved 
glass jar and transferred through a sterilized lock into the tank filled with disinfectant.  
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3.1.3 Establishment of GF mice 
 
Establishment of new strains of GF mice requires that the fetus remain sterile in the uterus. 
The pups are most commonly delivered by sterile Caesarean section and then transferred 
while still in the uterine sac to a GF foster mother (Figure 3.4). Thereafter, it is relatively 
straightforward to maintain and breed colonies of GF mice in isolators with free access to 
autoclaved food and water (162, 165). It is not advisable to use the first generation of GF 
mice for experiments, since their mother was not GF and virus, bacteria and bacterial 
metabolites can be transmitted transplacentally from the mother to the fetus.  At our facility, 
the GF status of the mice is confirmed weekly by in-house quality assurance involving 
collection of fecal samples to be cultured for aerobic and anaerobic bacteria and fungi.  For 
bacteria that cannot be cultured, 16S PCR testing is occasionally performed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Establishment of GF mice by Caesarian section. (A) The uterine sack is removed and 
clamped together at the top of each  horn and at the base close to the cervix. (B) The uterine 
sac is placed in a  glass jar containing desinfectant. (C) The uterine sack is transfered into the 
isolator, where it is opened and the pups removed cleaned and stimulated to breath. (D) The 
pups are introduced to the GF foster mother. 
3.1.4 Establishment of the control group for GF mice 
GF and gnotobiotic mice are  compared to the specific pathogen-free (SPF) animals free from 
known pathogens that causes clinical or subclinical infections that can bias research findings 
(162). Although SPF mice are usually housed in special rooms (including the ones at our 
facility), for reliable comparison they should be housed in the same environment as the GF 
mice (i.e., also in isolators), but this is seldom done because isolators are too expensive.  
Our SPF mice are screened and tested for pathogens 3 or 4 times a year, as recommended by 
the Federation of Laboratory Animal Science Associations (166).  In this connection, one SPF 
mouse from each rack is sent to the National Veterinary Institute (Uppsala, Sweden), along 
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with GF mice, which are always negative for pathogens. It is important to note that SPF animals 
are normally colonized with commensal bacteria, but the diversity and type of colonization is 
rarely known with any accuracy. To achieve balanced and identified colonization, commercial 
breeders and animal facilities tend to expose SPF mice to the modified Schaedler flora, 
containing 8 species of bacteria, 5 belonging to the genera Clostridium, Eubacterium, and 
Bacteroides; one a spirochete from the Flexistipes group (Mucispirillum schaederli); and two  
Lactobacillus species (162).  
3.1.5 Anatomical and physiological characteristics of GF mice 
 
If their diet is supplemented with vitamins, including K and B, GF mice are viable and healthy 
However, these animals show a number of important developmental and physiological 
differences in comparison to SPF animals. For example, the cecum is enlarged by 4-8-fold 
due to the accumulation of mucus and undigested fibers. This is in contrast to other GF 
animals, including dogs, pigs, sheep, goats and chickens that due to the anatomy of the 
junction between their small and large intestine show little or no such enlargement. When 
body weight is corrected for cecal weight adult GF rodents weigh less than their SPF 
counterparts.   
 
Moreover, the small intestine of GF rodents is less developed, with a considerably smaller 
surface area, slower peristalsis, irregular villi and reduced renewal of epithelial cells.  
Consequently, the ability of GF animals to utilize nutrients is compromised. Interestingly, 
GF rats live longer and develop spontaneous cancers less frequently than  SPF rats (159).  GF 
animals are also more prone to infections and have altered immune systems.  Additional 
differences between SPF and GF mice are presented in Table 3.1.  
 
3.1.6 The advantages and disadvantages for GF mice as experimental models 
GF and gnotobiotic mice are valuable experimental tools for examining host-microbe 
interactions. GF mice can be selectively colonized with a single bacteria, as we monocolonized 
them by oral gavage with B.thetaiotaomicron (Bteta) (Paper II) and with Clostridium 
tyrobutyricum (CBUT) (Papers II and III).  Furthermore, genetically modified mice can be 
made germ-free in order to study interactions between any particular gene and the microbiome. 
The major questions concerning host-microbe interactions include how colonies of microbiota 
are established and maintained, how these affect their host,  how the host shapes the populations 
of microbiota and how the microbiota influence the development of diseases. However, 
information obtained by comparing GF and SPF mice cannot be directly applied to humans 
and it often remains uncertain whether a disruption in the microbiota associated with a disease 
in humans is a cause, contributing factor, or merely a consequence of the disease state.  
Although such comparisons provide hints concerning the pathogenesis of diseases such as 
cancer, cardiovascular disease, diabetes and multiple sclerosis, the underlying mechanisms 
remain unknown and as a result, GF findings can seldom be readily translated into treatments 
and/or prevention.  
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Several factors could contribute to this failure. One caveat is that several bacterial species that 
colonize the murine gut are not found in humans. Secondly, the immune responses of mice 
differ from those of humans.  Furthermore, the distinct physiology and anatomy (including 
skin, fur, orapharyneal structures and compartmentalization of the GIT) and behavior (e.g., 
coprophagia) of mice will undoubtedly influence microbial communities (4, 9, 20, 161, 167).  
Despite these pitfalls, the GF mouse remains the most powerful model system for studying 
host-microbe interactions.  
3.2 PERMEABILITY TESTS 
Various experimental procedures are utilized to assess the integrity of blood-tissue barriers.  
Here we employed three methods to evaluate the permeability of the BPB, BBB and BTB. 1) 
Evans blue perfusion in Papers II and III. This fairly new approach involves perfusing the 
anesthetized mouse intracardially with the tracer (the Evans blue dye, MW 961 Da) and the 
standard fixative solution of formaldehyde (168).  Evans blue (EB) emits red fluoresce when 
bound to proteins, predominately serum albumin (MW 65 kDa) (169) and leakage of EB-
albumin through the barrier can be observed under the fluorescence microscope.  This method 
is inexpensive and, unlike more quantitative optical densitometry, enables localization of the 
areas of the barriers that are disrupted and visualization of the structures affected. Another 
advantage is that perfusion with EB is more rapid than traditional intravenous or intraperitoneal 
injection of the tracer which must be allowed to distribute in the body (168).  However, to 
obtain reliable results the perfusion rate must be kept low enough as not to damage capillaries 
and/or disrupt the barriers.  
2) Positron emission tomography (PET), utilized for the BBB in Paper II, involves 
intravenous injection of a tracer, the extravasation of which can then be visualized in real time. 
This method is a non-invasive, with no need to sacrifice the mice, and highly sensitive and also 
allows quantitation of tissue radioactivity and calculation of kinetic parameters of permeability. 
Its main drawbacks are its very high cost and the fact that the animal is exposed to radiation 
(170).  
3) Tracer injections, utilized for the BPB in Paper I and BBB in Paper II,  involves intravenous 
injection of a tracer; then  allowing time for it to distribute  (30 min-2 hr), sacrificing the mouse; 
and finally examining  extravasation of the tracer usually by fluorescence microscopy. This is 
the most common approach and a broad spectrum of tracers with different molecular sizes can 
be used to obtain detailed information about the extent, nature, and dynamics of barrier 
impairment (139). However, such tracer extravasation might not reveal minor alternations in 
barrier function. Furthermore, in comparison to EB perfusion, this approach resulted in less 
intense staining of disrupted areas of the BBB (168).  
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Table 3.1. Anatomical and physiological features of germ‐free mice that differ from those of 
specific‐pathogen‐free and wild‐type mice (162).  
Characteristic  Difference
Nutrition  Requirement for vitamins K and B in diet
Decreased percentage body fat 
Normal or increased food intake 
Fluid balance  Increased intake of water
Metabolism  Decreased basal metabolic rate
Increased secretion of free amino acids and urea and little excretion of 
acetic acid 
More urea and little ammonia in intestinal contents 
More nitrogen in the cecal contents and feces 
Elevated oxidation‐reduction potential of the cecal contents 
Altered response to anesthetics 
Circulation  Reduced total volume of blood
Decreased cardiac output 
Decreased blood flow to skin, liver, lungs and digestive tract 
Increased cholesterol level, numbers of red blood cells and hematocrit in 
blood 
Liver  Reduced size
Increased levels of ferritin and cholesterol 
Lungs  Thinner alveolar and capsular walls
Fewer reticuloendothelial elements 
Intestinal morphology  Reduction in total intestinal mass
Decrease in the total surface area of the small intestine 
Slender and uniform villi of the small intestine 
Shorter ileal villi and longer duodenal villi 
Shorter crypts of the small intestine 
Lamina propria of the small intestine thinner, with fewer cells and slower 
cell renewal 
Larger cecum with a thinner wall 
Intestinal motility  Increased muscle tissue, with elongated and hypertrophied muscle cells in 
the cecum 
Longer transit time 
Intestinal physiology  Reduced osmolarity in the small intestine
Elevated oxygen tension and electropotential in the small intestine 
Intestinal function  Enhanced absorption  of vitamins and minerals, alterations in the 
absorption of other ingested materials 
Altered enzyme content, elevated levels of typsin, chymotrypsin and 
invertase in the feces 
High levels of mucin (mucoproteins and mucopolysaccharides) in the feces 
Less fatty acids and no cyclic or branched‐chain fatty acids in the intestinal 
content, excretion of primarily unsaturated fatty acids  
Endocrine function  Less uptake of iodine by the thyroid
Decreased motor activity and hyperresponsiveness to epinephrine, 
norephinephrine and vasopressin 
Electrolyte status  More alkaline cecal contents
High levels of calcium and citrate and little phosphate in the urine 
Somewhat less sodium and low levels of chloride in the intestinal content 
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4 RESULTS AND DISCUSSION 
4.1 PAPER I: COMMENSAL MICROBIOTA SUPPORTS PLACENTAL 
DEVELOPMENT AND MATERNAL METABOLISM 
Animal who lay eggs will deposit a fixed amount of energy in the yolk sac. In contrast, 
mammals have evolved a more complex and flexible system to provide energy to the growing 
offspring. As gestation progresses, the metabolic demands on the mother increases to ensure 
sufficient supply of nutrient to the growing fetus.  Accumulating evidence indicate that gut 
microbiota and their metabolites act as critical regulators of metabolism in adults (171).  
However, much less is known about such metabolic-microbial interaction during pregnancy.  
In Paper I, I assessed the maternal microbiome and its potential influence on pregnancy and 
placental development. We demonstrated that the serum levels of glucocorticoids in GF dams 
are elevated even in the absence of pregnancy, which is indicative of metabolic stress. Indeed, 
this metabolic stress may explain the observation that GF mice must spend approximately 30% 
more time eating in order to maintain their body weight (172).  Moreover, corticosterone levels 
in serum are normally elevated during pregnancy (173) in order to secure glucose and the 
additional elevation when GF female mice become pregnant indicates that the maternal 
microbiome may contribute to metabolic support to the female during pregnancy. 
During pregnancy, the predominant source of energy for the offspring are carbohydrates (174)  
and ketone bodies (175) provided by the mother. However, in a situation of nutritional 
constrain, placental development may be impaired and placental structures altered to optimise 
nutrient transfer and secure sufficient energy for the offspring (176). In early pregnancy, 
following embryo implantation and decidualization, formation of the placental labyrinth 
requires a considerable amount of energy in order to develop correctly.  We found that the 
morphology of the GF placenta is impaired, with reduced labyrinth size, disrupted 
vascularization and reduced development of barrier functions in late gestation.  
Our analysis designed to correlate such morphological differences to metabolic parameters 
revealed that hepatic gluconeogenesis, lipolysis and ketogenesis were enhanced to meet the 
increased nutritional demands by the growing fetus. During late pregnancy, ANGPTL4 was 
specifically activated in order to block lipoprotein lipase in GF, but not in SPF dams further 
underscoring the severe metabolic stress experienced by the former. These finding indicates 
that in rodents, at least, the maternal microbiome plays an important role in optimizing 
metabolic functions during pregnancy, modulating maternal lipid and carbohydrate metabolism 
and regulating placental development. 
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                                               Figure 4.1 Graphic summary of Paper I 
 
4.2 PAPER II: THE GUT MICROBIOTA INFLUENCES BLOOD-BRAIN BARRIER 
PERMEABILITY IN MICE 
 As described above, the gut microbiota influence several key processes in the brain, including 
synaptogenesis and production of neurotransmitters and neurotrophic factors, thus apparently 
contributing to normal brain development and function (177).  It is also well known that the 
development and function of the brain require a functional BBB to ensure an optimal 
microenvironment (177).  
In Paper II, we assessed the potential impact of the gut microbiota on BBB integrity and thus 
permeability by comparing specific-pathogen-free (SPF) mice, germ-free (GF) mice and GF-
mice colonized with a complete SPF flora. 
Injection of an antibody carrying a moiety that absorbs infrared light into pregnant mice and 
subsequent imaging revealed that at around E17 this antibody penetrated the brain parenchyma 
of GF but not SPF foetuses. Complementary studies in adults using several independent 
techniques (i.e. Evans blue (EB) perfusion, [11C]Raclopride PET imaging and i.v. injection of 
an antibody) demonstrated that this BBB “leakiness” is observed in the adult GF mice as well. 
In vivo imaging using TRITC-Dextran and staining for pericytes showed no major quantitative 
differences in the structure of larger brain vessels in GF and SPF brains. Although we cannot 
totally exclude differences in microcapillary structures.  We did observe decreases in the levels 
of the tight junction proteins (TJPs) occludin and claudin 5 in the GF brain, which could  be 
partially reversed by faecal transfer of microbiota to adult GF mice.   
Perfusion with Evans blue revealed that monocolonization of the intestine of adult GF mice 
with either Clostridium tyrobutyricum (CBUT), a bacterial strain that produces butyrate, or oral 
administration of the bacterial metabolite butyrate, was sufficient to reduce BBB permeability 
(Figure 4.2).  This effect of gut microbiota and butyrate may be mediated by an epigenetic 
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mechanism, since administration of butyrate or monocolonization with CBUT elevated levels 
of histone acetylation in brain lysates. 
The results in Paper II, underscore our previous findings that the gut microbes can contribute 
to brain development and function (177). Our findings indicate that the gut microbiota may be 
one of several environmental cues that contribute to the BBB integrity required for correct 
spatial and temporal programming of brain development and maturation. TJPs, the target of 
microbiota, control endothelial polarity and impart the high transendothelial electrical 
resistance that restrict permeability and result in immune quiescence. Moreover, our present 
observations may have implications for understanding the development of neurodegenerative 
diseases known to involve altered BBB permeability. 
4.3 PAPER III: THE GUT MICROBIOTA AND DEVELOPMENTAL 
PROGRAMMING OF THE TESTIS IN MICE. 
In this study we found that the lack of gut microbiota can lower sperm count, levels of 
testosterone, expression of TJPs and increase permeability of the BTB in adult GF mice.  
Moreover, development of the BTB at postnatal day 16 was also affected with significantly 
fewer open tubules in the testes of GF than SPF males, a difference that can be reversed by 
colonization of the GF animals with CBUT.  Perfusion with Evans blue demonstrated restored 
BTB permiability when GF mice were either colonized with SPF microbiota (CV),  
monocolonized with CBUT or treated with butyrate (NaBu) (Figure 4.2).  
 
In addition to underscoring the importance of the gut microbiota for the establishment of 
barriers to protect reproductive organs, these findings indicate the essential role of the 
microbiota in regulating testosterone levels and sperm count.  It is tempting to speculate that 
probiotic supplementation might improve sperm count in men suffering from oligospermia and 
azoospermia. 
Figure 4.2. Evans blue (EB – red) and nuclear staining (DAPI – blue) of brain frontal cortex 
(upper panel) and seminiferous tubules (lower panel) of adult SPF, GF, CV, CBUT and NaBu 
mice.  Arrowheads:  brain  blood  vessels  and  interstitial  cells  of  the  testis.  Arrows:  EB 
extravasation into the brain parenchyma and the lumen of seminiferous tubules. 
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5 CONCLUSIONS AND FUTURE PERSPECTIVE 
 
This thesis support that our microbes are important regulators of host barriers protecting 
immune-privileged organs such as the placenta, brain and testis. Why should microbes be 
involved in regulation of barrier integrity and functions?  Perhaps as a way to improve the host 
innate immunity as these physical barriers represent the first line of defense against foreign 
molecules and pathogens.  Such protection will also favor the growth and survival of the 
microbiota. Moreover, results from this thesis further support the model that maternal microbes 
are important regulators of metabolism during pregnancy. To what extent these findings can 
explain some of the GF phenotypes previously reported in adults remains an open question.   
 
Future studies should focus on unraveling the signaling pathways and the identification of the 
metabolites involved in the establishment of barrier functions. Such research may improve our 
understanding of host-microbe crosstalk and perhaps pave the way for novel microbiota-based 
interventions.  Detailed characterization of bacterial metabolites (e.g., SCFA) and target genes 
could prove fruitful in this context?  
 
However, many questions regarding maternal host-microbe interaction during pregnancy remain 
un-answered. How does the microbiota communicate with the fetus through the placenta? How 
does it control maternal metabolism? Here, we focused on one metabolic maternal organ, the 
liver, and maternal adipose tissue and muscle should also be examined. Is the supply of 
probiotics to mothers during pregnancy and perhaps during lactation something to consider?  
Future studies should also address the potential involvement of microbes in pregnancy-
associated diseases such as pre-eclampsia and gestational diabetes mellitus.    
 
In addition, our data imply that microbes can modulate testosterone production. It is therefore 
of great interest to consider evaluating whether host microbes can influence prostate function, 
a testosterone-dependent organ. In addition, is there an association between certain microbes 
and prostate hyperplasia and/or prostate cancer?  It is still puzzling that even though male GF 
mice have an altered BTB and very low levels of testosterone, they are nonetheless fertile. How 
do these animals compensate and reproduce? Moreover, I focused here on the influence of 
microbiota on the primary male reproductive organ, the testis, and it will now be of 
considerable importance to look at the female gonads, the ovaries, as well as the potential 
effects of microbiota on levels of female hormones (estrogen and progesterone).  
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